340B Drug Pricing Program
AHA, others file briefs in Maryland, West Virginia to prevent injunctions against 340B pricing for contract pharmacy arrangements
AHA et al Amicus Brief to Prevent Injunction Against 340B Pricing for Contract Pharmacy Arrangements in Novartis v. Morrissey Litigation
UNITED STATES DISTRICT COURTFOR THE SOUTHERN DISTRICT OF DISTRICT OF WEST VIRGINIA
In a letter submitted July 2 to the Centers for Medicare & Medicaid Services on guidance for the Medicare Drug Price Negotiation Program, the AHA expressed concern about the agency’s proposal to retrospectively effectuate the policy.
AHA shares feedback on the Centers for Medicare & Medicaid Services’ draft guidance on the Medicare drug price negotiation program.
A Mississippi judge yesterday denied Novartis Pharmaceuticals’ and PhRMA’s request for a preliminary injunction against enforcement of state law protecting 340B pricing for contract pharmacy arrangements.
A Mississippi judge July 1 denied Novartis Pharmaceuticals’ and PhRMA’s request for a preliminary injunction against enforcement of state law protecting 340B pricing for contract pharmacy arrangements.
The AHA, 340B Health, the Maryland Hospital Association and the Mid-Atlantic Association of Community Health Centers yesterday filed an amicus brief in a federal district court in Maryland, defending the state's law protecting 340B pricing for contract pharmacy arrangements.
The AHA, 340B Health, the Maryland Hospital Association and the Mid-Atlantic Association of Community Health Centers June 26 filed an amicus brief in a federal district court in Maryland, defending the state's law protecting 340B pricing for contract pharmacy arrangements.
UNITED STATES DISTRICT COURTFOR THE DISTRICT OF MARYLAND